-- To support further clinical translation and commercialization of exosome drugs, the 7 th Exosome Summit will address topics on characterization, purification and potency testing, GMP production, and optimization of delivery routes.
Exosomes, which are a novel class of drug delivery vehicles, have exhibited exceptional loading capacity and are remarkably biocompatible and less immunogenic. However, three aspects of exosome-based products remaining major issues are stable products, efficient delivery, and scalable production. To resolve these issues, Creative Biolabs utilizes its proprietary LipidSync platform and offers integrated services from drug design to performance optimization to aid researchers and pharma companies in expediting therapeutic exosome development.
LipidSync™ Exosome Drug Delivery System
In exosome therapeutics, the delivery efficiency is of the utmost importance in terms of clinical translation. Creative Biolabs has purposefully constructed a novel exosome drug delivery system that has a high capacity to encapsulate small molecules, drugs, peptides/proteins and nucleic acids. More enhanced and targeted cellular uptake through surface engineering and structural optimization is more available than before.
Additionally, the platform employs new and improved sustained-release technologies aimed at achieving in vivo controllable and sustained release. This not only decreases the dosage frequency but also augments therapeutic effectiveness—which mirrors this year's summit focus on "delivery route assessment and expedited drug commercialization."
Exosome Performance Optimization
Apart from the delivery mechanism, exosome storage and operational stability are also critical for clinical translation. Creative Biolabs offers end-to-end solutions with every facet of the encapsulation process, surface modification, and performance optimization. Its LipidSync™ exosome performance optimization service has the following features:
* Solubility Improvement
Drug bioavailability and therapeutic efficacy are improved, guaranteeing effective delivery by the optimization of lipid composition, surface modification, and appropriate dispersion of particles.
* Lyophilization/Freezing Test
Comprehensive lyophilization and freezing solutions promote the stability and shelf life of the exosome while facilitating storage, transportation, and application.
* Stability Optimization
Using lipid selection, particle size control, and stabilizers can help maintain performance and functionality during the entire shelf life.
Improving bioavailability and durability has increased outcome reliability of drug development. As the company's chief scientist noted, "Exosomes serve different purposes in different disease models. We aim to assist our customers in identifying the most appropriate carriers and streamlining workflows to ensure reliable and rapid delivery."
In addition to delivery and performance optimization, Creative Biolabs also offers a broad portfolio of exosome research and development services, including characterization, nucleic acid delivery, and functional validation—supporting clients from early discovery to preclinical validation.
Register now to join Creative Biolabs at the summit and witness the next leap forward in exosome-based therapeutics!
About
Creative Biolabs welcomes industry partners to network with its team at the 7th Exosome-Based Therapeutic Development Summit, where it will be reviewing the future of exosome therapeutics with specialists from across the world.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/exosome/
Release ID: 89169753
Google
RSS